Company intelligence / Profile preview

RISA Labs

Palo Alto, California, United Statesrisalabs.ai ↗

Ownership: Private
Development stage: Commercial

Overview

RISA Labs has developed an AI-powered platform called BOSS that automates prior authorization and other administrative workflows in oncology care. At leading US cancer centers, BOSS reduced prior authorization times from 30 minutes to under five minutes, processed over $1 million in medications within months, freed up 80% of staff time, and cut administrative costs by 66%. The system aims to eliminate treatment delays caused by manual processes and fragmented payer guidelines.

Therapeutic areas: Oncology
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Collaborations with clearing houses and payer portals like AvailityUpdated guidelines from MCG and Interqual integrated into the platform

Beyond the preview

Go deeper on RISA Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RISA Labs.

Explore the full profile